Study uses novel incentive to encourage HIV patient care and treatment

July 17, 2012

In a new study by ICAP at Columbia's Mailman School of Public Health, researchers are assessing a novel approach to encourage newly diagnosed HIV positive people to seek care and adhere to HIV treatment. The unique study in the HIV Prevention Trials Network (HPTN) gives people who test HIV positive a coupon for a gift card to claim after they complete clinic visits and laboratory tests. Patients who adhere to HIV treatment regularly can decrease the amount of HIV in their blood, leading to viral suppression. Study participants who achieve viral suppression also receive gift cards as a reward and motivation for a maximum of four times a year.

Dr. Wafaa El-Sadr, ICAP director, is protocol chair for the HPTN 065 or Test Link to Care Plus Treat (TLC-Plus) Study. HPTN 065 is being conducted in the Bronx and in Washington, DC and involves 37 HIV testing sites and 39 HIV care sites in the two communities. HPTN 065 aims to determine the feasibility of enhanced testing, linkage and treatment as a strategy for HIV prevention in the U.S.

Community input played an important role in the design of the study, explained Dr. El-Sadr, who is also professor of Epidemiology and Medicine at Columbia's Mailman School. "Before we introduced our financial incentive, we had to think so carefully about what can happen that's good and what can undermine what you're trying to do," she said. "And we want to use incentives that, if they are effective, will be cost-effective for health systems."

Findings of the study are featured in Science magazine's July 13 special issue, "HIV/AIDS in America," published on the eve of the International AIDS Conference (AIDS 2012) in Washington, D.C.

Explore further: Expanding HIV treatment for couples could significantly reduce global HIV epidemic

Related Stories

New book on HIV from Cold Spring Harbor Laboratory Press

December 15, 2011

The worldwide AIDS epidemic makes research on HIV, the disease processes it induces, and potential HIV therapies among the most critical in biomedical science. Furthermore, the basic biology of HIV infections provides a model ...

Lessons learned from the 'ethical odyssey' of an HIV trial

June 14, 2012

In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve. The landmark HIV Prevention Trials Network (HPTN) 052 study, which established that antiretroviral ...

Recommended for you

Targeting HIV in semen to shut down AIDS

August 18, 2015

There may be two new ways to fight AIDS—using a heat shock protein or a small molecule - to attack fibrils in semen associated with the human immunodeficiency virus (HIV) during the initial phases of infection, according ...

Vitamin D status related to immune response to HIV-1

June 15, 2015

Vitamin D plays an important part in the human immune response and deficiency can leave individuals less able to fight infections like HIV-1. Now an international team of researchers has found that high-dose vitamin D supplementation ...

HVTN 505 vaccine induced antibodies nonspecific for HIV

July 30, 2015

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.